BioNxt provides development and IP update across sublingual pipeline
BioNxt (BNXTF) issues a development, intellectual property, and commercial update across its sublingual drug delivery pipeline.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.